BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 9054819)

  • 1. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries.
    Cox JL; Lee E; Langer A; Armstrong PW; Naylor CD
    CMAJ; 1997 Feb; 156(4):497-505. PubMed ID: 9054819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I.
    Kaul P; Armstrong PW; Chang WC; Naylor CD; Granger CB; Lee KL; Peterson ED; Califf RM; Topol EJ; Mark DB
    Circulation; 2004 Sep; 110(13):1754-60. PubMed ID: 15381645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.
    Mark DB; Hlatky MA; Califf RM; Naylor CD; Lee KL; Armstrong PW; Barbash G; White H; Simoons ML; Nelson CL
    N Engl J Med; 1995 May; 332(21):1418-24. PubMed ID: 7723799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with delay in reperfusion therapy in elderly patients with acute myocardial infarction: analysis of the cooperative cardiovascular project.
    Berger AK; Radford MJ; Krumholz HM
    Am Heart J; 2000 Jun; 139(6):985-92. PubMed ID: 10827378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
    Tricoci P; Lokhnygina Y; Berdan LG; Steinhubl SR; Gulba DC; White HD; Kleiman NS; Aylward PE; Langer A; Califf RM; Ferguson JJ; Antman EM; Newby LK; Harrington RA; Goodman SG; Mahaffey KW
    Circulation; 2007 Dec; 116(23):2669-77. PubMed ID: 18025532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential cost effectiveness of intravenous tissue plasminogen activator versus streptokinase for acute myocardial infarction.
    Goel V; Naylor CD
    Can J Cardiol; 1992; 8(1):31-8. PubMed ID: 1617509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of thrombolytic therapy in relation to hospital size and invasive cardiac services. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
    Barbash GI; White HD; Modan M; Diaz R; Hampton JR; Heikkila J; Kristinsson A; Moulopoulos S; Paolasso EA; Van der Werf T
    Arch Intern Med; 1994 Oct; 154(19):2237-42. PubMed ID: 7944845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing the time to thrombolysis in acute myocardial infarction. Time to Thrombolysis Substudy of the National Registry of Myocardial Infarction-1.
    Lambrew CT; Bowlby LJ; Rogers WJ; Chandra NC; Weaver WD
    Arch Intern Med; 1997 Dec 8-22; 157(22):2577-82. PubMed ID: 9531226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The delay to thrombolysis: an analysis of hospital and patient characteristics. Quebec Acute Coronary Care Working Group.
    Brophy JM; Diodati JG; Bogaty P; Théroux P
    CMAJ; 1998 Feb; 158(4):475-80. PubMed ID: 9627559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
    Berrocal DH; Cohen MG; Spinetta AD; Ben MG; Rojas Matas CA; Gabay JM; Magni JM; Nogareda G; Oberti P; Von Schulz C; Doval H; Bazzino OO; Cagide A; Oliveri R; Grinfeld LR
    Am Heart J; 2003 Dec; 146(6):E22. PubMed ID: 14661011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombolytic therapy in acute myocardial infarct--is it being used to the fullest?].
    Carôla B; Calçada-Correia L; Pedro PG; Conduto R; Dionísio I; Fiuza M; Dias E; Vaz Carneiro A; Amador MG; de Pádua F; Lopes MG
    Rev Port Cardiol; 1996 Dec; 15(12):867-76, 863. PubMed ID: 9052962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features associated with pre-hospital time delay in acute myocardial infarction.
    Berton G; Cordiano R; Palmieri R; Guarnieri G; Stefani M; Palatini P
    Ital Heart J; 2001 Oct; 2(10):766-71. PubMed ID: 11721721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Platelet activation in the early phases of acute myocardial infarction].
    Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
    Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigators.
    Chang WC; Fu Y; Ohman EM; Gupta M; Morris A; Roth SN; Granger CB; Califf RM; Topol EJ; Mark DB; Armstrong PW
    Can J Cardiol; 2000 Oct; 16(10):1231-9. PubMed ID: 11064297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombolytic therapy for acute myocardial infarction: circadian sensitivity].
    Kharash LM; Goldkhammer EI
    Ter Arkh; 1999; 71(12):13-7. PubMed ID: 10647192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the cost-effectiveness of thrombolytic therapy in acute myocardial infarct using tissue plasminogen activator or streptokinase:the Italian perspective].
    Lorenzoni R; Fattore G; Gensini G
    G Ital Cardiol; 1997 Jul; 27(7):721-6. PubMed ID: 9303862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angioplasty: determinants and outcome. Results from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausarzte.
    Zahn R; Vogt A; Zeymer U; Gitt AK; Seidl K; Gottwik M; Weber MA; Niederer W; Mödl B; Engel HJ; Tebbe U; Senges J;
    Heart; 2005 Aug; 91(8):1041-6. PubMed ID: 16020592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergency department triage of acute myocardial infarction patients and the effect on outcomes.
    Atzema CL; Austin PC; Tu JV; Schull MJ
    Ann Emerg Med; 2009 Jun; 53(6):736-45. PubMed ID: 19157653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there evidence of implicit exclusion criteria for elderly subjects in randomized trials? Evidence from the GUSTO-1 study.
    Krumholz HM; Gross CP; Peterson ED; Barron HV; Radford MJ; Parsons LS; Every NR
    Am Heart J; 2003 Nov; 146(5):839-47. PubMed ID: 14597933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.